JPY 193.0
(1.05%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 950.37 Million JPY | -29.59% |
2022 | 1.34 Billion JPY | -45.73% |
2021 | 2.48 Billion JPY | -19.7% |
2020 | 3.09 Billion JPY | 98.88% |
2019 | 1.55 Billion JPY | 0.4% |
2018 | 1.55 Billion JPY | 18.26% |
2017 | 1.31 Billion JPY | -2.5% |
2016 | 1.34 Billion JPY | -3.8% |
2015 | 1.39 Billion JPY | -23.46% |
2014 | 1.82 Billion JPY | 44.23% |
2013 | 1.26 Billion JPY | -9.09% |
2012 | 1.39 Billion JPY | 9.6% |
2011 | 1.27 Billion JPY | 16.83% |
2010 | 1.08 Billion JPY | -48.54% |
2009 | 2.11 Billion JPY | 38.6% |
2008 | 1.52 Billion JPY | 4.82% |
2007 | 1.45 Billion JPY | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 FY | 950.37 Million JPY | -29.59% |
2023 Q3 | 233.91 Million JPY | -3.96% |
2023 Q2 | 243.55 Million JPY | -20.48% |
2023 Q1 | 306.27 Million JPY | 457.93% |
2023 Q4 | 166.63 Million JPY | -28.76% |
2022 Q1 | 384.9 Million JPY | -37.13% |
2022 FY | 1.34 Billion JPY | -45.73% |
2022 Q4 | 54.89 Million JPY | -86.93% |
2022 Q3 | 420.03 Million JPY | -14.27% |
2022 Q2 | 489.93 Million JPY | 27.29% |
2021 FY | 2.48 Billion JPY | -19.7% |
2021 Q1 | 673.9 Million JPY | -19.11% |
2021 Q3 | 591.29 Million JPY | -3.01% |
2021 Q2 | 609.64 Million JPY | -9.54% |
2021 Q4 | 612.25 Million JPY | 3.54% |
2020 Q1 | 719.32 Million JPY | 35.28% |
2020 FY | 3.09 Billion JPY | 98.88% |
2020 Q2 | 764.73 Million JPY | 6.31% |
2020 Q3 | 780.21 Million JPY | 2.02% |
2020 Q4 | 833.11 Million JPY | 6.78% |
2019 Q1 | 284.66 Million JPY | -42.97% |
2019 Q2 | 297.93 Million JPY | 4.66% |
2019 Q3 | 443.1 Million JPY | 48.72% |
2019 Q4 | 531.73 Million JPY | 20.0% |
2019 FY | 1.55 Billion JPY | 0.4% |
2018 FY | 1.55 Billion JPY | 18.26% |
2018 Q3 | 341.5 Million JPY | -8.45% |
2018 Q2 | 373.02 Million JPY | 10.49% |
2018 Q1 | 337.6 Million JPY | -11.21% |
2018 Q4 | 499.15 Million JPY | 46.16% |
2017 Q1 | 277.89 Million JPY | -24.66% |
2017 Q4 | 380.22 Million JPY | 22.0% |
2017 Q3 | 311.66 Million JPY | -8.87% |
2017 Q2 | 341.99 Million JPY | 23.07% |
2017 FY | 1.31 Billion JPY | -2.5% |
2016 Q1 | 255.92 Million JPY | -6.86% |
2016 FY | 1.34 Billion JPY | -3.8% |
2016 Q3 | 306.9 Million JPY | -25.83% |
2016 Q4 | 368.84 Million JPY | 20.18% |
2016 Q2 | 413.76 Million JPY | 61.68% |
2015 Q2 | 425.56 Million JPY | 13.21% |
2015 FY | 1.39 Billion JPY | -23.46% |
2015 Q4 | 274.77 Million JPY | -14.77% |
2015 Q3 | 322.39 Million JPY | -24.24% |
2015 Q1 | 375.9 Million JPY | -7.63% |
2014 Q2 | 463.85 Million JPY | 23.75% |
2014 Q3 | 581.7 Million JPY | 25.41% |
2014 Q4 | 406.94 Million JPY | -30.04% |
2014 FY | 1.82 Billion JPY | 44.23% |
2014 Q1 | 374.82 Million JPY | 28.21% |
2013 Q2 | 378.37 Million JPY | 22.33% |
2013 Q4 | 292.35 Million JPY | 1.91% |
2013 FY | 1.26 Billion JPY | -9.09% |
2013 Q3 | 286.87 Million JPY | -24.18% |
2013 Q1 | 309.31 Million JPY | -33.22% |
2012 Q2 | 446.54 Million JPY | 175.07% |
2012 Q3 | 321.44 Million JPY | -28.01% |
2012 Q4 | 463.2 Million JPY | 44.1% |
2012 FY | 1.39 Billion JPY | 9.6% |
2012 Q1 | 162.33 Million JPY | -54.77% |
2011 FY | 1.27 Billion JPY | 16.83% |
2011 Q2 | 331.12 Million JPY | 3.82% |
2011 Q3 | 262.51 Million JPY | -20.72% |
2011 Q4 | 358.93 Million JPY | 36.73% |
2011 Q1 | 318.93 Million JPY | 18.48% |
2010 Q2 | 185.37 Million JPY | -48.2% |
2010 Q1 | 357.86 Million JPY | 10.29% |
2010 FY | 1.08 Billion JPY | -48.54% |
2010 Q3 | 275.87 Million JPY | 48.82% |
2010 Q4 | 269.18 Million JPY | -2.42% |
2009 Q2 | 592.45 Million JPY | 22.08% |
2009 FY | 2.11 Billion JPY | 38.6% |
2009 Q4 | 324.47 Million JPY | -54.45% |
2009 Q3 | 712.42 Million JPY | 20.25% |
2009 Q1 | 485.31 Million JPY | 20.16% |
2008 Q1 | 465.28 Million JPY | 0.0% |
2008 FY | 1.52 Billion JPY | 4.82% |
2008 Q4 | 403.9 Million JPY | 15.95% |
2008 Q3 | 348.34 Million JPY | 13.02% |
2008 Q2 | 308.21 Million JPY | -33.76% |
2007 FY | 1.45 Billion JPY | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 14.28 Billion JPY | 93.346% |
DNA Chip Research Inc. | 66.35 Million JPY | -1332.304% |
Cosmo Bio Company,Limited | 3.25 Billion JPY | 70.758% |
H.U. Group Holdings, Inc. | 63.23 Billion JPY | 98.497% |
FALCO HOLDINGS Co., Ltd. | 12.71 Billion JPY | 92.526% |
BML, Inc. | 45.62 Billion JPY | 97.917% |
Human Metabolome Technologies, Inc. | 869.33 Million JPY | -9.323% |